Table 5.
Clinical validation phase (phase 2): laboratory parameters (N = 529) cohort
Investigation | Value (mean ± SD) |
---|---|
Hemoglobin (g/dl) | 12.3 ± 3.3 |
HbA1c (%) | 8.01 ± 3.1 |
Serum Albumin (g/l) | 3.7 ± 1.4 |
Serum creatinine (mg/dl) | 0.7 ± 0.7 |
eGFR (ml/min per 1.73 m2) | 90 ± 38 |
Total cholesterol (mg/dl) | 157 ± 70 |
LDL cholesterol (mg/dl) | 83 ± 46 |
Triglycerides (mg/dl) | 183 (149) |
eGFR, estimated glomerular filtration rate; HbA1c, glycosylated hemoglobin; LDL, low-density lipoprotein.